Develops implantable brain electrodes to treat epilepsy, profound deafness, incontinence and Parkinson’s disease.
Conducts clinical trials of a promising new drug that is designed to target prostate cancer cells and arrest its progression to more advanced stages.
Focuses on the molecular genetics of cancer by tumor profiling and through clinical diagnostic testing.
Magnetic Resonance Center
The clinical application of magnetic resonance spectroscopy (MRS) to study chemical changes in the body associated with brain tumors, hydrocephalus, liver disease, Alzheimer’s and other neurological disorders.
Identifies the specific proteins in cerebrospinal fluid associated with disorders of the nervous system including Alzheimer’s and Parkinson’s diseases, multiple sclerosis, migraine and depression.
Studies telomerase as a potential molecular marker to identify patients at high risk of breast and prostate cancer.
Liver Research Program
Medical management of hepatitis viruses and liver cancer with emphasis on research into the pathology and treatment of hepatitis B and C.
In Vitro Systems/Tissue Engineering
Uses microgravity bioreactors to study cell interactions in tumor tissue, develop organ regeneration and improve cancer therapies.